Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.

× No keyword cloud information.

17 in total

Review 1. Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients.

Authors: Mojdeh S Heavner; Kimberly C Claeys; Anne M Masich; Jeffrey P Gonzales
Journal: Curr Infect Dis Rep Date: 2018-04-05 Impact factor: 3.725

2. Application of guidelines for aminoglycosides use in French hospitals in 2013-2014.

Authors: J Robert; Y Péan; S Alfandari; J-P Bru; J-P Bedos; C Rabaud; R Gauzit
Journal: Eur J Clin Microbiol Infect Dis Date: 2017-01-09 Impact factor: 3.267

3. A study to evaluate the first dose of gentamicin needed to achieve a peak plasma concentration of 30 mg/l in patients hospitalized for severe sepsis.

Authors: N Allou; Y Charifou; P Augustin; T Galas; D Valance; L Corradi; O Martinet; D Vandroux; J Allyn
Journal: Eur J Clin Microbiol Infect Dis Date: 2016-05-03 Impact factor: 3.267

4. Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize A Priori Pharmacokinetic/Pharmacodynamic Target Attainments in Individual Patients.

Authors: Clément Boidin; Laurent Bourguignon; Sabine Cohen; Claire Roger; Jean-Yves Lefrant; Jason A Roberts; Bernard Allaouchiche; Alain Lepape; Arnaud Friggeri; Sylvain Goutelle
Journal: Antimicrob Agents Chemother Date: 2019-10-22 Impact factor: 5.191

5. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.

Authors: Cédric Carrié; Faustine Delzor; Stéphanie Roure; Vincent Dubuisson; Laurent Petit; Mathieu Molimard; Dominique Breilh; Matthieu Biais
Journal: Antimicrob Agents Chemother Date: 2020-03-24 Impact factor: 5.191

6. Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients.

Authors: Celeste Bloomfield; Christine E Staatz; Sean Unwin; Stefanie Hennig
Journal: Antimicrob Agents Chemother Date: 2016-05-23 Impact factor: 5.191

Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.

Review 1. Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients.

2. Application of guidelines for aminoglycosides use in French hospitals in 2013-2014.

3. A study to evaluate the first dose of gentamicin needed to achieve a peak plasma concentration of 30 mg/l in patients hospitalized for severe sepsis.

4. Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize A Priori Pharmacokinetic/Pharmacodynamic Target Attainments in Individual Patients.

5. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.

6. Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients.

7. Local Injection of Aminoglycosides for Prophylaxis Against Infection in Open Fractures.

8. Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction.

Review 9. De-repressing LncRNA-Targeted Genes to Upregulate Gene Expression: Focus on Small Molecule Therapeutics.

10. Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.